Screening for prostate cancer with prostate-specific antigen. An examination of the evidence.
about
PSA testing for prostate cancer: an online survey of the views and reported practice of General Practitioners in the UKEffects of hyperprolactinemia on rat prostate growth: evidence of androgeno-dependence.The PSA testing dilemma: GPs' reports of consultations with asymptomatic men: a qualitative studyDetection of early prostate cancer using a hepsin-targeted imaging agent.Biomarkers for early and late stage chronic allograft nephropathy by proteogenomic profiling of peripheral blood.Differentiating prostate disorders.Treatment decisions for localized prostate cancer: asking men what's important.Hereditary breast cancer. Identifying and managing BRCA1 and BRCA2 carriers.Prostate cancer: 1. The descriptive epidemiology in Canada.Prostate-specific antigen testing in Ontario: reasons for testing patients without diagnosed prostate cancer.Identification of an antibody fragment specific for androgen-dependent prostate cancer cells.The effect of disease prevention and health promotion on workplace productivity: a literature review.Posttransplantation care: role of the primary care physician versus transplant center.Prevention. How much harm? How much benefit? 4. The ethics of informed consent for preventive screening programs.Physician perspectives on the importance of facts men ought to know about prostate-specific antigen testingAlpha1-adrenergic receptors activate Ca(2+)-permeable cationic channels in prostate cancer epithelial cells.Brief report: physicians and their personal prostate cancer-screening practices with prostate-specific antigen. A national survey.Acute onset-low back pain and hip pain secondary to metastatic prostate cancer: a case report.Optimization of PSA screening policies: a comparison of the patient and societal perspectivesSpecific aspects of erectile function in urology/andrology.Is screening for prostate cancer with prostate specific antigen an appropriate public health measure?PSA testing: an evolving relationship with prostate cancer screening.Physician-patient discussions of controversial cancer screening testsLatest tests for prostatic neoplasia.Prostate carcinoma knowledge, attitudes, and screening behavior among African-American men in Central Harlem, New York City.Intermediate-conductance Ca2+-activated K+ channels (IKCa1) regulate human prostate cancer cell proliferation through a close control of calcium entry.Dominance of the alpha1B-adrenergic receptor and its subcellular localization in human and TRAMP prostate cancer cell lines.Notch signalling and voltage-gated Na+ channel activity in human prostate cancer cells: independent modulation of in vitro motility.Patient-Provider Communication About Prostate Cancer Screening and Treatment: New Evidence From the Health Information National Trends Survey.Volume-regulated chloride conductance in the LNCaP human prostate cancer cell line.Preventive medicine and screening in older adults.Common urologic disorders. When to treat and when to refer.Evaluation of the fibroblast growth factor system as a potential target for therapy in human prostate cancer.Variation in KLK genes, prostate-specific antigen and risk of prostate cancer.Serum 25-hydroxyvitamin D concentrations and risk of prostate cancer: results from the Prostate Cancer Prevention Trial.PSA screening: a view from the front lines. North York General-Branson Practice-Based Small Group.Screening without evidence of efficacy.A guinea pig's view on prostate cancer screening trials.FGFR3 mutations in prostate cancer: association with low-grade tumors.Use of electronic medical records to identify patients at risk for prostate cancer in an academic institution.
P2860
Q24814107-C2F7EFD7-1434-48B3-9999-A4A54B7BF2F9Q31712792-E39D3736-C429-4913-99FF-33F505947161Q33288928-5A77944A-AE5D-4724-86EF-8A2698CC3FA5Q33326514-FC9354B2-FA6E-4BF2-87D1-A52DDE3E67DFQ33480997-9CA41347-9CDE-4DB9-A0CD-6D75C11023F1Q33543410-97FBCD0C-8960-4A36-A53A-5C3ADEA38888Q33843865-42895BE7-FF0E-48DC-9A4D-A1CF7FD2AC53Q33964990-644FB2D5-48F5-4824-81CB-912DD888A5D3Q34029605-D9B2551C-7FDF-4665-A3B9-76F7459BCB07Q34030385-51042275-1F88-48D9-90AE-ACD0C6E6B1DCQ34152258-9A7E8DA4-60CB-4528-AC54-01ABC66EE926Q34193795-1A0BCFE1-D2E8-4FBA-8BEB-20055B9B9D90Q34426362-33348FD5-B1C2-411F-AED9-39A908E9FCD1Q34712987-3905BDC6-6EA4-4D46-B3F9-EF127F65D22EQ34741600-DAA50CD7-6EB6-44B1-B573-225EA9C80CA8Q35019287-26757FB5-239B-4DA4-882C-967ECEB5021CQ35688261-1B8C9475-611F-4119-839D-066FDC971DECQ35729693-555A3149-3B39-4A6E-BA51-8D37E686BC76Q35783202-B7C71D51-57BF-43A8-BC4F-1F80F705B7D1Q35924328-4BA73262-0732-4031-9F7E-5CD22B381F5DQ36217132-1855DD75-A599-433B-BEFD-39A7E556B81DQ36325601-0D77827A-8BD7-4462-B5B5-951D3C0E91E8Q36844437-41339576-01A1-48C0-83C9-A4BC4B0245EEQ37222117-FDF7AAC9-6827-4CC7-B410-B92436D28F89Q39556191-F422C4A2-0F62-4049-9590-CF97CFBFEA93Q39875520-42BEBAA0-FF1F-45B0-BB70-948E4CA2A798Q40158040-3FB589DB-B843-4DAE-BBBD-0308CABF7419Q40256852-4502ABB0-0669-4CE3-A6DB-3524A33A0BB6Q40266746-7A33A483-EEDD-4267-9634-37CA9EFECD1AQ40852795-83CC4827-4039-4B55-A3EF-8796FBD0766CQ41377536-50742294-6B86-4EB1-9AA2-2300D5123BD4Q41577002-DBD3FFA5-D9C0-4B33-9768-C0C88A90513BQ42558926-2FC0D49F-A412-403A-AFEC-E832CDC9662AQ42725643-E8DCF3D6-38A6-4D9C-A96B-4732207B0FA9Q42766017-C038990D-C0BD-4D60-9B82-B4946809EB26Q43013882-3EE36D39-1E2B-442D-99A7-1A2FCAD0F31EQ43155149-2D823B05-972F-4263-8776-9CACB03848A6Q46872796-B0263B87-1A79-4D8B-9845-9ABE5798FBB1Q47984250-CCF1E56E-9DE0-4CF4-AC60-52D5BE80E399Q51739513-FE5A5F97-0CB6-486A-A254-F1348B5504A2
P2860
Screening for prostate cancer with prostate-specific antigen. An examination of the evidence.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Screening for prostate cancer ...... n examination of the evidence.
@en
type
label
Screening for prostate cancer ...... n examination of the evidence.
@en
prefLabel
Screening for prostate cancer ...... n examination of the evidence.
@en
P1476
Screening for prostate cancer ...... n examination of the evidence.
@en
P2093
P304
P356
10.1056/NEJM199511233332107
P407
P577
1995-11-01T00:00:00Z